|This Slide: #81 of 100|
Slide #81. BC Acquisition Corp. — BioClinica
BC Acquisition Corp.
BioClinica, Inc., a leading global provider of clinical trial management solutions and JLL Partners, Inc., a leading private equity investment firm, announced today that BC Acquisition Corp. ("Purchaser"), which is a wholly-owned subsidiary of BioCore Holdings, Inc. ("Parent"), each of which is an affiliate of JLL, has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. The offer is being made pursuant to a definitive merger agreement pursuant to which Parent will acquire BioClinica. Parent and Purchaser are affiliates of JLL Partners Fund VI, L.P. (the "Sponsor"), which is a private equity investment fund managed by JLL.
Strong Buy (4.00 out of 4)
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite